Literature DB >> 22019016

Help-seeking and treatment preferences for depression in epilepsy.

Kerrie L Margrove1, Ajay K Thapar, Seth A Mensah, Michael P Kerr.   

Abstract

Depression among people with a diagnosis of epilepsy is common, underrecognized, and undertreated, yet the reasons for this are unclear. In this study people with a diagnosis of epilepsy recruited from primary care were mailed a questionnaire covering help seeking for psychological distress, treatment preferences for depression, and current symptoms of depression using the Patient Health Questionnaire-2 (PHQ2). Eighty-six people with epilepsy responded to the survey and 44% of the sample reported they would not seek help if they were feeling stressed, worried, or low and it was affecting their daily lives. Almost 40% of the participants screened positive for current depression and PHQ2 scores were statistically unchanged over an average of 8.6 months. The most popular treatment for depression was advice from a general practitioner or from family and friends. The majority of respondents felt speed of treatment should take priority over receiving preferred treatment for depression care.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22019016     DOI: 10.1016/j.yebeh.2011.08.042

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

1.  A primary healthcare screening tool to identify depression and anxiety disorders among people with epilepsy in Zambia.

Authors:  Edward K Mbewe; Leana R Uys; Ntombifikile M Nkwanyana; Gretchen L Birbeck
Journal:  Epilepsy Behav       Date:  2013-03-17       Impact factor: 2.937

2.  Neurologist prescribing versus psychiatry referral: Examining patient preferences for anxiety and depression management in a symptomatic epilepsy clinic sample.

Authors:  Heidi M Munger Clary; Rachel D Croxton; Beverly M Snively; Gretchen A Brenes; James Lovato; Fatemeh Sadeghifar; James Kimball; Cormac O'Donovan; Kelly Conner; Esther Kim; Jonathan Allan; Pamela Duncan
Journal:  Epilepsy Behav       Date:  2020-11-24       Impact factor: 2.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.